Federation des caisses Desjardins du Quebec’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-103
| Closed | -$319 | – | 2863 |
|
|
2025
Q1 | $319 | Buy |
103
+100
| +3,333% | +$486 | ﹤0.01% | 2537 |
|
|
2024
Q4 | $23 | Hold |
3
| – | – | ﹤0.01% | 2534 |
|
|
2024
Q3 | $40 | Hold |
3
| – | – | ﹤0.01% | 2527 |
|
|
2024
Q2 | $76 | Hold |
3
| – | – | ﹤0.01% | 2395 |
|
|
2024
Q1 | $219 | Hold |
3
| – | – | ﹤0.01% | 2295 |
|
|
2023
Q4 | $246 | Hold |
3
| – | – | ﹤0.01% | 2248 |
|
|
2023
Q3 | $285 | Hold |
3
| – | – | ﹤0.01% | 2254 |
|
|
2023
Q2 | $465 | Hold |
3
| – | – | ﹤0.01% | 2198 |
|
|
2023
Q1 | $921 | Hold |
3
| – | – | ﹤0.01% | 2165 |
|
|
2022
Q4 | $875 | Sell |
3
-23
| -88% | -$6.18K | ﹤0.01% | 2296 |
|
|
2022
Q3 | $6.8K | Hold |
26
| – | – | ﹤0.01% | 2006 |
|
|
2022
Q2 | $8.57K | Hold |
26
| – | – | ﹤0.01% | 2001 |
|
|
2022
Q1 | $15.6K | Hold |
26
| – | – | ﹤0.01% | 1897 |
|
|
2021
Q4 | $15.6K | Buy |
26
+23
| +767% | +$21.6K | ﹤0.01% | 1910 |
|
|
2021
Q3 | $3.37K | Sell |
3
-1
| -25% | -$1.25K | ﹤0.01% | 2342 |
|
|
2021
Q2 | $5.34K | Hold |
4
| – | – | ﹤0.01% | 2223 |
|
|
2021
Q1 | $9.5K | Hold |
4
| – | – | ﹤0.01% | 2017 |
|
|
2020
Q4 | $7.09K | Hold |
4
| – | – | ﹤0.01% | 1988 |
|
|
2020
Q3 | $9.85K | Hold |
4
| – | – | ﹤0.01% | 1687 |
|
|
2020
Q2 | $10.4K | Hold |
4
| – | – | ﹤0.01% | 1630 |
|
|
2020
Q1 | $9.79K | Hold |
4
| – | – | ﹤0.01% | 1679 |
|
|
2019
Q4 | $9.46K | Hold |
4
| – | – | ﹤0.01% | 1903 |
|
|
2019
Q3 | $3.62K | Hold |
4
| – | – | ﹤0.01% | 2020 |
|
|
2019
Q2 | $4.54K | Hold |
4
| – | – | ﹤0.01% | 2005 |
|
|
2019
Q1 | $3.53K | Hold |
4
| – | – | ﹤0.01% | 1868 |
|
|
2018
Q4 | $3.24K | Hold |
4
| – | – | ﹤0.01% | 1852 |
|
|
2018
Q3 | $4.58K | Hold |
4
| – | – | ﹤0.01% | 1894 |
|
|
2018
Q2 | $6.88K | Hold |
4
| – | – | ﹤0.01% | 1844 |
|
|
2018
Q1 | $5.65K | Sell |
4
-10
| -71% | -$13.4K | ﹤0.01% | 1840 |
|
|
2017
Q4 | $14.1K | Sell |
14
-1
| -7% | -$773 | ﹤0.01% | 1648 |
|
|
2017
Q3 | $9.59K | Sell |
15
-6
| -29% | -$4.03K | ﹤0.01% | 1684 |
|
|
2017
Q2 | $11.6K | Hold |
21
| – | – | ﹤0.01% | 1693 |
|
|
2017
Q1 | $9.7K | Buy |
+21
| New | +$10.8K | ﹤0.01% | 1437 |
|
Other funds holding APTO
DS
GG
TWC
CSC
Federation des caisses Desjardins du Quebec's APTO Position: Q2 2025 in Review
Federation des caisses Desjardins du Quebec sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 103 shares — an estimated $319 sold.
Federation des caisses Desjardins du Quebec first reported a position in APTO in Q1 2017 and held it in 33 quarters. The position peaked at $15.6K in Q4 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.
- Federation des caisses Desjardins du Quebec reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 103 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $319.
- Federation des caisses Desjardins du Quebec first reported a position in Aptose Biosciences, Inc. in Q1 2017 and held it in 33 quarters.
- Federation des caisses Desjardins du Quebec's Aptose Biosciences, Inc. position peaked at $15.6K in Q4 2021.
- 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.